Fortress Biotech, Inc. (FBIO) fundamentals score
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holding and dividend and royalty revenue streams. Fortress works in concert with its extensive network of key opinion leaders to identify and evaluate promising products and product candidates for potential acquisition.
Pharmaceutical Preparations · Healthcare · Listed on NASDAQ
Overall: 5.8 out of 10, Mixed fundamentals
- Growth: 6.3/10
- Profitability: 5.4/10
- Financial health: 5.4/10
- Earnings quality: 4.2/10
- Valuation: 8.0/10
Scores are calculated from Fortress Biotech, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10